BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
Want to see BBOT full AI Analyst Report?
Technical Sentiment
Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
BridgeBio Oncology Therapeutics’s (BBOT) Moving Averages Convergence Divergence (MACD) indicator is -0.31, suggesting BridgeBio Oncology Therapeutics is a Buy.
BridgeBio Oncology Therapeutics’s (BBOT) 20-Day exponential moving average is 8.09, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 50-Day exponential moving average is 8.57, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics (BBOT) Pivot Points
Classic
6.40
6.74
6.93
7.26
7.45
7.79
7.98
Fibonacci
6.74
6.94
7.06
7.26
7.46
7.59
7.79
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
BridgeBio Oncology Therapeutics (BBOT) Moving Averages
MA5
7.49Sell
7.52Sell
MA10
7.95Sell
7.80Sell
MA20
8.31Sell
8.09Sell
MA50
8.52Sell
8.57Sell
MA100
9.48Sell
9.26Sell
MA200
10.59Sell
10.05Sell
BridgeBio Oncology Therapeutics’s (BBOT) 10-Day exponential moving average is 7.80, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 100-Day exponential moving average is 9.26, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 50-day simple moving average is 8.52, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 100-day simple moving average is 9.48, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 200-day simple moving average is 10.59, creating a Sell signal.
BridgeBio Oncology Therapeutics (BBOT) Technical Indicators
RSI (14)
38.59
Neutral
STOCH (9,6)
9.12
Buy
STOCHRSI (14)
8.07
Buy
MACD (12,26)
-0.31
Buy
ADX (14)
17.67
Buy
Williams %R
-79.56
Buy
CCI (14)
-160.14
Buy
ATR (14)
0.56
-
Ultimate Oscillator
35.33
Neutral
ROC
-18.11
Sell
BridgeBio Oncology Therapeutics’s (BBOT) Relative Strength Index (RSI) is 38.59, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Trend Strength Indicator (ADX) is 17.67, creating a Buy signal.
BridgeBio Oncology Therapeutics’s (BBOT) Commodity Channel Index (CCI) is -160.14, creating a Buy signal.
BridgeBio Oncology Therapeutics’s (BBOT) Price Rate of Change (ROC) is -18.11, creating a Sell signal.
FAQ
Is BBOT a Buy, Hold, or Sell?
Based on BBOT’s technical indicators, BBOT is a Sell.
What is BBOT’s RSI (14)?
BBOT’s RSI (14) is 38.59, which suggests BBOT is a Neutral.
What is BBOT’s MACD?
BBOT’s MACD is -0.31, which suggests BBOT is a Buy.
What is BBOT’s 5-day moving average?
BBOT’s 5-day moving average is 7.49, which suggests BBOT is a Sell.
What is BBOT’s 20-day moving average?
BBOT 20-day moving average is 8.31, which suggests BBOT is a Sell.
What is BBOT’s 50-day moving average?
BBOT’s 50-day moving average is 8.52, which suggests BBOT is a Sell.
What is BBOT’s 200-day moving average?
BBOT’s 200-day moving average is 10.59, which suggests BBOT is a Sell.
What is BBOT’s Williams % R (14)?
BBOT’s Williams % R (14) is -79.56, which suggests BBOT is a Buy.
What is BBOT’s CCI (14)?
BBOT’s CCI (14) is -160.14, which suggests BBOT is a Buy.